Literature DB >> 23838228

Public reporting of hospital-acquired infections is not associated with improved processes or outcomes.

Darren R Linkin1, Neil O Fishman, Judy A Shea, Wei Yang, Mark S Cary, Ebbing Lautenbach.   

Abstract

Most US states have enacted or are considering legislation mandating hospitals to publicly report hospital-acquired infection (HAI) rates. We conducted a survey of infection control professionals and found that state-legislated public reporting of HAIs is not associated with perceived improvements in infection prevention program process measures or HAI rates.

Entities:  

Mesh：

Year:  2013        PMID： 23838228      PMCID： PMC3979462          DOI： 10.1086/671279

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  6 in total

1.  Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes?

Authors:  Daniel J Sexton; Luke F Chen; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10-27       Impact factor: 3.254

2.  National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009.

Authors:  Jonathan R Edwards; Kelly D Peterson; Yi Mu; Shailendra Banerjee; Katherine Allen-Bridson; Gloria Morrell; Margaret A Dudeck; Daniel A Pollock; Teresa C Horan
Journal:  Am J Infect Control       Date:  2009-12       Impact factor: 2.918

3.  Influence of cardiac-surgery performance reports on referral practices and access to care. A survey of cardiovascular specialists.

Authors:  E C Schneider; A M Epstein
Journal:  N Engl J Med       Date:  1996-07-25       Impact factor: 91.245

4.  Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee.

Authors:  Linda McKibben; Teresa Horan; Jerome I Tokars; Gabrielle Fowler; Denise M Cardo; Michele L Pearson; Patrick J Brennan
Journal:  Am J Infect Control       Date:  2005-05       Impact factor: 2.918

5.  Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates.

Authors:  Michael Y Lin; Bala Hota; Yosef M Khan; Keith F Woeltje; Tara B Borlawsky; Joshua A Doherty; Kurt B Stevenson; Robert A Weinstein; William E Trick
Journal:  JAMA       Date:  2010-11-10       Impact factor: 56.272

6.  Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.

Authors:  Deron C Burton; Jonathan R Edwards; Teresa C Horan; John A Jernigan; Scott K Fridkin
Journal:  JAMA       Date:  2009-02-18       Impact factor: 56.272
  6 in total
  5 in total

1.  Enhancement of health department capacity for health care-associated infection prevention through Recovery Act-funded programs.

Authors:  Katherine Ellingson; Kelly McCormick; Ronda Sinkowitz-Cochran; Tiffanee Woodard; John Jernigan; Arjun Srinivasan; Kimberly Rask
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

Review 2.  Infection Prevention in the Hospital from Past to Present: Evolving Roles and Shifting Priorities.

Authors:  Michelle Doll; Angela L Hewlett; Gonzalo Bearman
Journal:  Curr Infect Dis Rep       Date:  2016-05       Impact factor: 3.725

3.  Impact of State Reporting Laws on Central Line-Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units.

Authors:  Hangsheng Liu; Carolyn T A Herzig; Andrew W Dick; E Yoko Furuya; Elaine Larson; Julie Reagan; Monika Pogorzelska-Maziarz; Patricia W Stone
Journal:  Health Serv Res       Date:  2016-07-24       Impact factor: 3.402

4.  Perceived impact of state-mandated reporting on infection prevention and control departments.

Authors:  Monika Pogorzelska-Maziarz; Pamela B de Cordova; Carolyn T A Herzig; Andrew Dick; Julie Reagan; Patricia W Stone
Journal:  Am J Infect Control       Date:  2018-10-12       Impact factor: 2.918

Review 5.  The impact of Public Reporting on clinical outcomes: a systematic review and meta-analysis.

Authors:  Paolo Campanella; Vladimir Vukovic; Paolo Parente; Adela Sulejmani; Walter Ricciardi; Maria Lucia Specchia
Journal:  BMC Health Serv Res       Date:  2016-07-22       Impact factor: 2.655
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.